Rare form of pancreatic cancer ‘could be targeted with immunotherapies’

New research into a rare form of cancer has been welcomed (David Davies/PA)

People suffering from a rare, hard-to-treat form of pancreatic cancer could be given targeted immunotherapies, new research suggests.

The results, by London’s Institute of Cancer Research (ICR), could help pick out those patients with pancreatic neuroendocrine cancer who are most likely to benefit from such treatment, a scientist involved in the work said.